Literature DB >> 26901835

Adapting coculture in vitro models of the blood-brain barrier for use in cancer research: maintaining an appropriate endothelial monolayer for the assessment of transendothelial migration.

Elodie Vandenhaute1, Aurore Drolez1, Emmanuel Sevin1, Fabien Gosselet1, Caroline Mysiorek1, Marie-Pierre Dehouck1.   

Abstract

Although brain metastases are the most common brain tumors in adults, there are few treatment options in this setting. To colonize the brain, circulating tumor cells must cross the blood-brain barrier (BBB), which is situated within specialized, restrictive microvascular endothelium. Understanding how cancer cells manage to transmigrate through the BBB might enable this process to be prevented. In vitro models are dedicated tools for characterizing the cellular and molecular mechanisms that underlie transendothelial migration process, as long as they accurately mimic the brain endothelium's in vivo characteristics. The objective of the present study was to adapt an existing in vitro model of the human BBB for use in studying cancer cell transmigration. The model is based on the coculture of endothelial cells (ECs, derived from cord blood hematopoietic stem cells) and brain pericytes. To allow the migration of cancer cells into the lower compartment, our model had to be transposed onto inserts with a larger pore size. However, we encountered a problem when culturing ECs on large (3-μm)-pore inserts: the cells crossed the membrane and formed a non-physiological second layer on the lower face of the insert. Using 3-μm-pore inserts (in a 12-well plate format), we report here on a method that enables the maintenance of a single monolayer of ECs on the insert's upper face only. Under these chosen conditions, the ECs exhibited typical BBB properties found in the original model (including restricted paracellular permeability and the expression of continuous tight junctions). This modified in vitro model of the human BBB enabled us to investigate the migratory potential of the MDA-MB-231 cell line (derived from highly metastatic human breast cancer cells). Last, the results obtained were compared with the rate of transmigration through endothelia with no BBB features.

Entities:  

Mesh:

Year:  2016        PMID: 26901835     DOI: 10.1038/labinvest.2016.35

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  30 in total

1.  In vitro model for evaluating drug transport across the blood-brain barrier.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-04-05       Impact factor: 15.470

2.  Organ-specificity of the extravasation process: an ultrastructural study.

Authors:  S Paku; B Döme; R Tóth; J Timár
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 3.  Crossing the endothelial barrier during metastasis.

Authors:  Nicolas Reymond; Bárbara Borda d'Água; Anne J Ridley
Journal:  Nat Rev Cancer       Date:  2013-12       Impact factor: 60.716

4.  Assessment of attachment factors for primary cultured human corneal endothelial cells.

Authors:  Christoph Engler; Clare Kelliher; Caroline L Speck; Albert S Jun
Journal:  Cornea       Date:  2009-10       Impact factor: 2.651

5.  Comparison of in vitro and in vivo approaches to studying brain colonization by breast cancer cells.

Authors:  M Lorger; H Lee; J S Forsyth; B Felding-Habermann
Journal:  J Neurooncol       Date:  2011-02-27       Impact factor: 4.130

6.  Tumor-stroma: In vivo assays and intravital imaging to study cell migration and metastasis.

Authors:  Zhen Ni Zhou; Pamela J Boimel; Jeffrey E Segall
Journal:  Drug Discov Today Dis Models       Date:  2011

7.  The proinflammatory peptide substance P promotes blood-brain barrier breaching by breast cancer cells through changes in microvascular endothelial cell tight junctions.

Authors:  Pedro L Rodriguez; Shuxian Jiang; Yigong Fu; Shalom Avraham; Hava Karsenty Avraham
Journal:  Int J Cancer       Date:  2013-09-03       Impact factor: 7.396

Review 8.  Breaking and entering into the CNS: clues from solid tumor and nonmalignant models with relevance to hematopoietic malignancies.

Authors:  Soumit K Basu; Scot C Remick; Manish Monga; Laura F Gibson
Journal:  Clin Exp Metastasis       Date:  2013-12-05       Impact factor: 5.150

9.  Improved survival, vascular differentiation and wound healing potential of stem cells co-cultured with endothelial cells.

Authors:  Dora C S Pedroso; Ana Tellechea; Liane Moura; Isabel Fidalgo-Carvalho; João Duarte; Eugénia Carvalho; Lino Ferreira
Journal:  PLoS One       Date:  2011-01-24       Impact factor: 3.240

10.  A stable and reproducible human blood-brain barrier model derived from hematopoietic stem cells.

Authors:  Romeo Cecchelli; Sezin Aday; Emmanuel Sevin; Catarina Almeida; Maxime Culot; Lucie Dehouck; Caroline Coisne; Britta Engelhardt; Marie-Pierre Dehouck; Lino Ferreira
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

View more
  15 in total

Review 1.  Use of porous membranes in tissue barrier and co-culture models.

Authors:  Henry H Chung; Marcela Mireles; Bradley J Kwarta; Thomas R Gaborski
Journal:  Lab Chip       Date:  2018-06-12       Impact factor: 6.799

2.  Materials for blood brain barrier modeling in vitro.

Authors:  Magali P Ferro; Sarah C Heilshorn; Roisin M Owens
Journal:  Mater Sci Eng R Rep       Date:  2020-01-06       Impact factor: 36.214

Review 3.  New experimental models of the blood-brain barrier for CNS drug discovery.

Authors:  Mohammad A Kaisar; Ravi K Sajja; Shikha Prasad; Vinay V Abhyankar; Taylor Liles; Luca Cucullo
Journal:  Expert Opin Drug Discov       Date:  2016-11-07       Impact factor: 6.098

4.  FVIII regulates the molecular profile of endothelial cells: functional impact on the blood barrier and macrophage behavior.

Authors:  Marie Cadé; Javier Muñoz-Garcia; Antoine Babuty; Louis Paré; Denis Cochonneau; Karim Fekir; Mathias Chatelais; Marie-Françoise Heymann; Anna Lokajczyk; Catherine Boisson-Vidal; Dominique Heymann
Journal:  Cell Mol Life Sci       Date:  2022-02-21       Impact factor: 9.261

Review 5.  Organ-On-A-Chip Models of the Blood-Brain Barrier: Recent Advances and Future Prospects.

Authors:  Satoru Kawakita; Kalpana Mandal; Lei Mou; Marvin Magan Mecwan; Yangzhi Zhu; Shaopei Li; Saurabh Sharma; Ana Lopez Hernandez; Huu Tuan Nguyen; Surjendu Maity; Natan Roberto de Barros; Aya Nakayama; Praveen Bandaru; Samad Ahadian; Han-Jun Kim; Rondinelli Donizetti Herculano; Eggehard Holler; Vadim Jucaud; Mehmet Remzi Dokmeci; Ali Khademhosseini
Journal:  Small       Date:  2022-08-17       Impact factor: 15.153

6.  Measuring barrier function in organ-on-chips with cleanroom-free integration of multiplexable electrodes.

Authors:  Elsbeth G B M Bossink; Mariia Zakharova; Douwe S de Bruijn; Mathieu Odijk; Loes I Segerink
Journal:  Lab Chip       Date:  2021-05-18       Impact factor: 6.799

7.  Serum-derived factors of breast cancer patients with brain metastases alter permeability of a human blood-brain barrier model.

Authors:  Carolin J Curtaz; Constanze Schmitt; Saskia-Laureen Herbert; Jonas Feldheim; Nicolas Schlegel; Fabien Gosselet; Carsten Hagemann; Norbert Roewer; Patrick Meybohm; Achim Wöckel; Malgorzata Burek
Journal:  Fluids Barriers CNS       Date:  2020-04-22

8.  Selection of a Relevant In Vitro Blood-Brain Barrier Model to Investigate Pro-Metastatic Features of Human Breast Cancer Cell Lines.

Authors:  Aurore Drolez; Elodie Vandenhaute; Sylvain Julien; Fabien Gosselet; Joy Burchell; Roméo Cecchelli; Philippe Delannoy; Marie-Pierre Dehouck; Caroline Mysiorek
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

9.  ST6GALNAC5 Expression Decreases the Interactions between Breast Cancer Cells and the Human Blood-Brain Barrier.

Authors:  Aurore Drolez; Elodie Vandenhaute; Clément Philippe Delannoy; Justine Hélène Dewald; Fabien Gosselet; Romeo Cecchelli; Sylvain Julien; Marie-Pierre Dehouck; Philippe Delannoy; Caroline Mysiorek
Journal:  Int J Mol Sci       Date:  2016-08-11       Impact factor: 5.923

Review 10.  Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles.

Authors:  Julien Saint-Pol; Fabien Gosselet; Sophie Duban-Deweer; Gwënaël Pottiez; Yannis Karamanos
Journal:  Cells       Date:  2020-04-01       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.